Updated: Apr 30, 2024
The average Theravance Biopharma stock price target is 16.50 with a max estimate of 21.00 and a min estimate of 10.00
Review Theravance Biopharma earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Apr 30, 2024